Status:
UNKNOWN
ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Collaborating Sponsors:
Fondation de France
Aix Marseille Université
Conditions:
HIV Seropositivity
Disclosure
Eligibility:
FEMALE
18+ years
Brief Summary
The objective of this research is to measure the short- and mid-term effects of an empowerment program focused on serostatus disclosure management for women living with HIV (WLHIV) in Mali on the "bur...
Detailed Description
Serostatus disclosure is a critical issue for persons living with HIV (PLHIV). Studies identified numerous benefits associated with disclosure, but various negative consequences have also been documen...
Eligibility Criteria
Inclusion
- women living with HIV
- living in Bamako area (Mali)
- over 18 years old
- knowing their serological status for more than 6 months and less than 5 years
- being available to participate in the 9 weekly sessions lasting about 2 hours each.
Exclusion
- having already participated in Gundo-So
Key Trial Info
Start Date :
May 27 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
224 Patients enrolled
Trial Details
Trial ID
NCT03795415
Start Date
May 27 2019
End Date
May 1 2021
Last Update
July 5 2019
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
CESAC de BAMAKO
Bamako, Mali
2
Usac Cnam
Bamako, Mali
3
USAC commune IV
Bamako, Mali
4
USAC commune I
Bamako, Mali